{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:39:10Z","timestamp":1789882750942,"version":"4.0.1"},"reference-count":36,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.241.239","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T22:13:00Z","timestamp":1490307180000},"page":"239-247","source":"Crossref","is-referenced-by-count":13,"title":["Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer"],"prefix":"10.1620","volume":"241","author":[{"given":"Ming","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Oncology, Linyi People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Linyi People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aunoble, B., Sanches, R., Didier, E. & Bignon, Y.J. (2000) Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int. J. Oncol.<\/i>, 16, 567-576.","DOI":"10.3892\/ijo.16.3.567"},{"key":"2","unstructured":"Bednarek, W., Wertel, I. & Kotarski, J. (2008) Lymphangiogenesis in cancerous tumours. Ginekol. Pol.<\/i>, 79, 625-629."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. & Wittwer, C.T. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem.<\/i>, 55, 611-622.","DOI":"10.1373\/clinchem.2008.112797"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chen, S.P., Yang, Q., Wang, C.J., Zhang, L.J., Fang, Y., Lei, F.Y., Wu, S., Song, L.B., Guo, X. & Guo, L. (2014) Transducin \u03b2<\/i>-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-\u03ba<\/i>B pathway. Mol. Cancer<\/i>, 13, 195.","DOI":"10.1186\/1476-4598-13-195"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Choi, H.K., Choi, K.C., Yoo, J.Y., Song, M., Ko, S.J., Kim, C.H., Ahn, J.H., Chun, K.H., Yook, J.I. & Yoon, H.G. (2011) Reversible SUMOylation of TBL1-TBLR1 regulates \u03b2<\/i>-catenin-mediated Wnt signaling. Mol. Cell<\/i>, 43, 203-216.","DOI":"10.1016\/j.molcel.2011.05.027"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Colombo, P.E., Fabbro, M., Theillet, C., Bibeau, F., Rouanet, P. & Ray-Coquard, I. (2014) Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer. Crit. Rev. Oncol. Hematol.<\/i>, 89, 207-216.","DOI":"10.1016\/j.critrevonc.2013.08.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Daniels, G., Li, Y., Gellert, L.L., Zhou, A., Melamed, J., Wu, X., Zhang, X., Zhang, D., Meruelo, D., Logan, S.K., Basch, R. & Lee, P. (2014) TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth. Endocr. Relat. Cancer<\/i>, 21, 127-142.","DOI":"10.1530\/ERC-13-0293"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Daniels, G., Zhang, X., Zhong, X., Santiago, L., Wang, L.H., Wu, X., Zhang, J.Y., Liang, F., Li, X., Neubert, T.A., Steinke, L., Shen, Y., Basch, R., Schneider, R., Levy, D.E., et al. (2016) Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation. Oncotarget<\/i>, 7, 39556-39571.","DOI":"10.18632\/oncotarget.9005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Goff, B.A., Mandel, L., Muntz, H.G. & Melancon, C.H. (2000) Ovarian carcinoma diagnosis. Cancer<\/i>, 89, 2068-2075.","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Guo, Y., Wang, J., Zhang, L., Shen, S., Guo, R., Yang, Y., Chen, W., Wang, Y., Chen, G. & Shuai, X. (2016) Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma. Hepatology<\/i>, 63, 1240-1255.","DOI":"10.1002\/hep.28409"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hoberg, J.E., Yeung, F. & Mayo, M.W. (2004) SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol. Cell<\/i>, 16, 245-255.","DOI":"10.1016\/j.molcel.2004.10.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hunn, J. & Rodriguez, G.C. (2012) Ovarian cancer: etiology, risk factors, and epidemiology. Clin. Obstet. Gynecol.<\/i>, 55, 3-23.","DOI":"10.1097\/GRF.0b013e31824b4611"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kuang, X., Zhu, J., Peng, Z., Wang, J. & Chen, Z. (2016) Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Dig. Dis. Sci.<\/i>, 61, 489-500.","DOI":"10.1007\/s10620-015-3879-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lan, C., Li, Y. & Liu, J. (2009) Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer. Gynecol. Oncol.<\/i>, 114, 42-47.","DOI":"10.1016\/j.ygyno.2009.03.034"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Li, J. & Wang, C.Y. (2008) TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. Nat. Cell Biol.<\/i>, 10, 160-169.","DOI":"10.1038\/ncb1684"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Li, X., Liang, W., Liu, J., Lin, C., Wu, S., Song, L. & Yuan, Z. (2014) Transducin (beta)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling. Breast Cancer Res.<\/i>, 16, 465.","DOI":"10.1186\/s13058-014-0465-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Liu, F., He, Y. & Cao, Q. (2016a) TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis. Dis. Markers<\/i>, 2016, 2436518.","DOI":"10.1155\/2016\/2436518"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Liu, H., Xu, Y., Zhang, Q., Yang, H., Shi, W., Liu, Z., Li, K., Gong, Z., Ning, S., Li, S. & Chen, Y. (2017) Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer. Surg. Oncol.<\/i>, 26, 13-20.","DOI":"10.1016\/j.suronc.2016.12.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Liu, H., Zhang, Q., Li, K., Gong, Z., Liu, Z., Xu, Y., Swaney, M.H., Xiao, K. & Chen, Y. (2016b) Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into beta-arrestin-dependent ERK signaling. Oncotarget<\/i>, 7, 81223-81240.","DOI":"10.18632\/oncotarget.13219"},{"key":"20","unstructured":"Ma, M. & Yu, N. (2016) Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis. Onco Targets Ther.<\/i>, 9, 1559-1569."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Perissi, V., Scafoglio, C., Zhang, J., Ohgi, K.A., Rose, D.W., Glass, C.K. & Rosenfeld, M.G. (2008) TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR\/SMRT transcriptional repression checkpoints. Mol. Cell<\/i>, 29, 755-766.","DOI":"10.1016\/j.molcel.2008.01.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Regan, E., Sibley, R.C., Cenik, B.K., Silva, A., Girard, L., Minna, J.D. & Dellinger, M.T. (2016) Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines. PLoS One<\/i>, 11, e0150963.","DOI":"10.1371\/journal.pone.0150963"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. (2014) Cancer statistics, 2014. CA Cancer J. Clin.<\/i>, 64, 9-29.","DOI":"10.3322\/caac.21208"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. (2012) Cancer statistics for Hispanics\/Latinos, 2012. CA Cancer J. Clin.<\/i>, 62, 283-298.","DOI":"10.3322\/caac.21153"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Siegel, R.L., Miller, K.D. & Jemal, A. (2015) Cancer statistics, 2015. CA Cancer J. Clin.<\/i>, 65, 5-29.","DOI":"10.3322\/caac.21254"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Tomita, A., Buchholz, D.R., Obata, K. & Shi, Y.B. (2003) Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo. J. Biol. Chem.<\/i>, 278, 30788-30795.","DOI":"10.1074\/jbc.M303309200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Tomita, A., Buchholz, D.R. & Shi, Y.B. (2004) Recruitment of N-CoR\/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development. Mol. Cell. Biol.<\/i>, 24, 3337-3346.","DOI":"10.1128\/MCB.24.8.3337-3346.2004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wang, J., Ou, J., Guo, Y., Dai, T., Li, X., Liu, J., Xia, M., Liu, L. & He, M. (2014) TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer. Br. J. Cancer<\/i>, 111, 112-124.","DOI":"10.1038\/bjc.2014.278"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Wang, L.H., Lin, C.Y., Liu, S.C., Liu, G.T., Chen, Y.L., Chen, J.J., Chan, C.H., Lin, T.Y., Chen, C.K., Xu, G.H., Chen, S.S., Tang, C.H. & Wang, S.W. (2016) CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells. Oncotarget<\/i>, 7, 36896-36908.","DOI":"10.18632\/oncotarget.9213"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Wen, P., Kong, R., Liu, J., Zhu, L., Chen, X., Li, X., Nie, Y., Wu, K. & Wu, J.Y. (2014) USP33, a new player in lung cancer, mediates Slit-Robo signaling. Protein Cell<\/i>, 5, 704-713.","DOI":"10.1007\/s13238-014-0070-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wu, Q.W., She, H.Q., Liang, J., Huang, Y.F., Yang, Q.M., Yang, Q.L. & Zhang, Z.M. (2012) Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer<\/i>, 12, 47.","DOI":"10.1186\/1471-2407-12-47"},{"key":"32","unstructured":"Wu, X., Zhan, Y., Li, X., Wei, J., Santiago, L., Daniels, G., Deng, F., Zhong, X., Chiriboga, L., Basch, R., Xiong, S., Dong, Y., Zhang, X. & Lee, P. (2016) Nuclear TBLR1 as an ER corepressor promotes cell proliferation, migration and invasion in breast and ovarian cancer. Am. J. Cancer Res.<\/i>, 6, 2351-2360."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yoon, H.G., Chan, D.W., Huang, Z.Q., Li, J., Fondell, J.D., Qin, J. & Wong, J. (2003) Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J.<\/i>, 22, 1336-1346.","DOI":"10.1093\/emboj\/cdg120"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Yuasa-Kawada, J., Kinoshita-Kawada, M., Rao, Y. & Wu, J.Y. (2009) Deubiquitinating enzyme USP33\/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc. Natl. Acad. Sci. USA<\/i>, 106, 14530-14535.","DOI":"10.1073\/pnas.0801262106"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zhang, J., Kalkum, M., Chait, B.T. & Roeder, R.G. (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell<\/i>, 9, 611-623.","DOI":"10.1016\/S1097-2765(02)00468-9"},{"key":"36","doi-asserted-by":"publisher","unstructured":"Zhou, Q., Wang, X., Yu, Z., Wu, X., Chen, X., Li, J., Zhu, Z., Liu, B. & Su, L. (2016) Transducin (\u03b2<\/i>)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1\/2 pathway. Oncogene<\/i>, doi: 10.1038\/onc.2016.352. [Epub ahead of print].","DOI":"10.1038\/onc.2016.352"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/3\/241_239\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T13:19:31Z","timestamp":1498396771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/3\/241_239\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.241.239","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}